Complete response of a primary cutaneous T-cell-rich B cell lymphoma treated with interferon α2a

Journal of Cancer Research and Clinical Oncology

Volumn 124, Issue 2, 1998, Pages 127-129

  Wollina, U ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Complete remission; Interferon 2a; Primary cutaneous B cell lymphoma

Indexed keywords

ALPHA2A INTERFERON;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CASE REPORT; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE;

ANTIGENS, CD20; ANTIGENS, CD3; BIOPSY; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRALESIONAL; INTERFERON ALFA-2A; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0031900664     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320050144     Document Type: Article

References (11)

1. Arai E, Sakurai M, Nakayama H, Morinaga S, Katayama I (1993) Primary cutaneous T-cell-rich B cell lymphoma. Br J Dermatol 129:196-200
2. Berti E, Alessi E, Caputo R, Gianotti R, Delia D, Vezzoni P (1988) Reticulohistiocytoma of the dorsum. J Am Acad Dermatol 19:259-272
3. Borzillo GV, Endo K, Tsujimoto Y (1992) Bcl-2 confers to growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene 7:869-876
4. Kerl H, Cerroni L (1997) Primary B cell lymphomas of the skin. Ann Oncol 8 [Suppl 2]:29-32
5. Kutting B, Bonsmann G, Metze D, Luger TA, Cerroni L (1997) Borrelia burgdorferi-associated primary cutaneous B cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a. J Am Acad Dermatol 36:311-314
6. Lundgren E, Hedman H, Landberg G, Chiang F, Roos G, Sanders R (1991) Molecular events in B-cell activation and growth: sensitivity to alpha interferon. Eur J Cancer 27 [Suppl 4]:S82-S84
7. McLaughlin P (1996) The role of interferon in the therapy of malignant lymphoma. Biomed Pharmacother 50:140 148
8. Oken MM (1996) New agents for the treatment of multiple myeloma and non-Hodgkin lymphoma. Cancer 70 [Suppl 4]:946 948
9. Santucci M, Pimpinelli N, Argani L (1991) Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases. Cancer 67:2311-2326
10. Tourani JM, Leaute JB, Lessana-Leibowitch M, Andrieu JM (1989) Complete remission following interferon alpha-2a in a patient with diffuse large B cell cutaneous lymphoma. Nouv Rev Fr Hematol 31:315-316
11. Zenone T, Catimel G, Barbet N and Clavel M (1994) Complete remission of a primary cutaneous B cell lymphoma treated with intralesional recombinant interferon alpha-2a. Eur J Cancer 30A:246-247